A study of usefulness of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and assessment of response to treatment in locally advanced breast cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: null- patients with locally advanced breast cancer
- Registration Number
- CTRI/2018/04/013455
- Lead Sponsor
- Sri Venkateswara Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
biopsy proven locally advanced breast cancer women
Exclusion Criteria
Patients with early breast cancer or found to have metastatic disease on conventional imaging will be excluded from the study. Patients who have already received treatment elsewhere will be excluded. Male patients with breast cancer will not be included.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the utility of FDG PET/CT in initial staging of locally advanced breast cancer. <br/ ><br>2.To compare FDG PET/CT with conventional methods in staging of locally advanced breast cancer <br/ ><br>3.To evaluate the role of FDG PET/CT in predicting pathological response to neoadjuvant chemotherapy in comparison to other methods <br/ ><br>4.Usefulness of PET/CTin selection of patients for breast conservation surgery vs mastectomy after NACT <br/ ><br>Timepoint: February 2015
- Secondary Outcome Measures
Name Time Method sefulness of PET/CTin selection of patients for breast conservation surgery vs mastectomy after NACT <br/ ><br>Timepoint: over 20 month period